Abstract: A method for preparing a stacked solid aluminum electrolytic capacitor is disclosed. The method includes preparation of a plurality of cores, stacking and fixing of the plurality of cores in a case and encapsulation of the case. The core is prepared through the following steps. An I-shaped aluminum foil is divided into an anode part and a cathode part by applying an insulating blocking tape, where the cathode part includes a dielectric layer, which is subjected to formation. A conductive polymer layer is formed on a surface of the cathode part, and is then impregnated with conductive colloidal graphite followed by drying to form a conductive carbon paste layer. The conductive carbon paste layer is impregnated with a conductive silver paste followed by drying to form a conductive silver paste layer. After that, a core is obtained.

Abstract: This application provides a multilayer solid aluminum electrolytic capacitor and a method for preparing the same. The multilayer solid aluminum electrolytic capacitor includes a plurality of cores, a rivet, a case, and a cover plate. The cores are stacked in sequence and fastened in the case through the rivet to form a semi-finished capacitor. The semi-finished capacitor is covered by the cover plate and then sealed to form the solid aluminum electrolytic capacitor.

Abstract: This application provides a multilayer solid aluminum electrolytic capacitor and a method for preparing the same. The multilayer solid aluminum electrolytic capacitor includes a plurality of cores, a rivet, a case, and a cover plate. The cores are stacked in sequence and fastened in the case through the rivet to form a semi-finished capacitor. The semi-finished capacitor is covered by the cover plate and then sealed to form the solid aluminum electrolytic capacitor.

Abstract: Provided are a recombinant adeno-associated virus (AAV) vector carrying human papillomavirus type 16 (HPV-16) mutation E7 antigen gene and a construction method therefor. The construction method comprises mutating the carcinogenic HPV-16 E7 antigen gene to noncarcinogenic E7 antigen gene, and then inserting the mutated gene into an AAV vector of which the structural gene has been removed, thereby obtaining the recombinant AAV vector. The recombinant AAV vector or related product can be used for preparing medications against HPV-16 infection and other diseases such as tumors caused by HPV-16 infection.

Abstract: A nanodevice has a containment vessel defining a storage chamber therein and defining at least one port to provide access to and from said storage chamber, and a stopper assembly attached to the containment vessel. The stopper assembly has a blocking unit arranged proximate the at least one port and has a structure suitable to substantially prevent material after being loaded into the storage chamber from being released while the blocking unit is arranged in a blocking configuration. The stopper assembly is responsive to the presence of a predetermined stimulus such that the blocking unit is released in the presence of the predetermined stimulus to allow the material to be released from the storage chamber. The predetermined stimulus is a predetermined catalytic activity that is suitable to at least one of cleave, hydrolyze, oxidize, or reduce a portion of the stopper assembly, and the nanodevice has a maximum dimension of about 1 ?m.